Barclays Remains a Sell on Waters (WAT)
TipRanksApr 10 14:48
Analysts Offer Insights on Healthcare Companies: Waters (WAT) and UnitedHealth (UNH)
TipRanksApr 5 12:20
Waters Analyst Ratings
BenzingaApr 5 01:04
Evercore ISI Group Maintains In-Line on Waters, Raises Price Target to $340
BenzingaApr 5 01:05
Waters Analyst Ratings
BenzingaFeb 13 01:29
Analysts Offer Insights on Healthcare Companies: Alnylam Pharma (ALNY), Waters (WAT) and Biohaven Ltd. (BHVN)
TipRanksFeb 12 21:32
Analysts' Opinions Are Mixed on These Healthcare Stocks: Baxter International (BAX) and Waters (WAT)
TipRanksFeb 12 09:20
UBS Adjusts Price Target on Waters to $345 From $285, Maintains Neutral Rating
MT NewswiresFeb 8 00:41
Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), Waters (WAT) and Bristol-Myers Squibb (BMY)
TipRanksFeb 7 21:30
Waters Corporation: Cautious Hold Amidst China Headwinds and Mixed Outlook
TipRanksFeb 7 21:26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN), Qiagen (QGEN) and Waters (WAT)
TipRanksFeb 7 10:30
BofA Securities Raises Price Target on Waters to $328 From $300, Maintains Neutral Rating
MT NewswiresJan 29 23:35
Barclays Maintains Underweight on Waters, Raises Price Target to $275
BenzingaJan 25 22:59
Waters Analyst Ratings
BenzingaJan 25 22:58
Waters Analyst Ratings
BenzingaDec 13, 2023 17:55
BofA Securities Adjusts Price Target on Waters to $300 From $265, Maintains Neutral Rating
MT NewswiresDec 12, 2023 23:47
Waters Analyst Ratings
BenzingaDec 11, 2023 20:14
Waters Corporation Downgraded at Barclays Citing Industry Headwinds
Seeking AlphaNov 14, 2023 00:15
Waters Analyst Ratings
BenzingaNov 13, 2023 21:19
Waters Analyst Ratings
BenzingaNov 9, 2023 04:49
No Data
No Data